Outpatient Infusion Systems is categorized under in Alpharetta, GA and active since 2003.
Outpatient Infusion Systems was established in 2003, and today employs 1 to 4, earning $10.000.000 to $19.9999.999 per year. This is a business, which does work in the B2B market, and is classified as a , under code number 4234502 by the NAICS.
If you are seeking more information, feel free to contact Christopher Good, Chief Executive Officer at the company’s single location by writing to 5950 Shiloh Road East # U, Alpharetta, Georgia GA 30005 or by phoning (678) 513-3849. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Outpatient Infusion Systems |
Contact Person: | Christopher Good, Chief Executive Officer |
Address: | 5950 Shiloh Road East # U, Alpharetta, Georgia 30005 |
Phone Number: | (678) 513-3849 |
Website Address: | ois-inc.net |
Annual Revenue (USD): | $10.000.000 to $19.9999.999 |
Founded: | 2003 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | |
SIC Code: | 5047 |
NAICS Code: | 4234502 |
Share This Business: |
Outpatient Infusion Systems was started in 2003 to provide professional under the SIC code 5047 and NAICS code 4234502. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $10.000.000 to $19.9999.999 per annum.
Feel free to contact Christopher Good, Chief Executive Officer for inquiries that concern Outpatient Infusion Systems by calling the company number (678) 513-3849, as your correspondence is most welcome. Additionally, the physical location of the single location of Outpatient Infusion Systems can be found at the coordinates 34.1207,-84.20059 as well as the street address 5950 Shiloh Road East # U in Alpharetta, Georgia 30005.
For its online presence, you may visit Outpatient Infusion Systems’s website at ois-inc.net and engage with its social media outlets through on Twitter and on Facebook.